Poor evidence for an effect of tecovirimat in shortening recovery time in hospitalized mpox cases from real-world data
View ORCID ProfileV Mazzotta, A Cozzi-Lepri, S Lanini, A Mondi, F Carletti, A Tavelli, R Gagliardini, S Vita, C Pinnetti, C Aguglia, P Faccendini, F Colavita, F Faraglia, A Beccacece, J Paulicelli, E Girardi, View ORCID ProfileE Nicastri, F Vaia, F Maggi, A Antinori
doi: https://doi.org/10.1101/2023.02.07.23285617
V Mazzotta
1Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
2PhD course in Microbiology, Immunology, Infectious Diseases, and Transplants (MIMIT), University of Rome Tor Vergata, Rome, Italy
A Cozzi-Lepri
3Centre for Clinical Research, Epidemiology, Modelling, and Evaluation (CREME), Institute for Global Health, UCL, London, UK
S Lanini
1Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
A Mondi
1Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
F Carletti
4Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
A Tavelli
5Clinic of Infectious Diseases, Department of Health Sciences, ASST Santi Paolo e Carlo, University of Milan, Italy
R Gagliardini
1Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
S Vita
1Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
C Pinnetti
1Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
C Aguglia
1Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
P Faccendini
6Pharmacy Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
F Colavita
4Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
F Faraglia
1Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
A Beccacece
1Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
J Paulicelli
1Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
E Girardi
7Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
E Nicastri
1Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
F Vaia
8General Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
F Maggi
4Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
A Antinori
1Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy
Posted February 10, 2023.
Poor evidence for an effect of tecovirimat in shortening recovery time in hospitalized mpox cases from real-world data
V Mazzotta, A Cozzi-Lepri, S Lanini, A Mondi, F Carletti, A Tavelli, R Gagliardini, S Vita, C Pinnetti, C Aguglia, P Faccendini, F Colavita, F Faraglia, A Beccacece, J Paulicelli, E Girardi, E Nicastri, F Vaia, F Maggi, A Antinori
medRxiv 2023.02.07.23285617; doi: https://doi.org/10.1101/2023.02.07.23285617
Poor evidence for an effect of tecovirimat in shortening recovery time in hospitalized mpox cases from real-world data
V Mazzotta, A Cozzi-Lepri, S Lanini, A Mondi, F Carletti, A Tavelli, R Gagliardini, S Vita, C Pinnetti, C Aguglia, P Faccendini, F Colavita, F Faraglia, A Beccacece, J Paulicelli, E Girardi, E Nicastri, F Vaia, F Maggi, A Antinori
medRxiv 2023.02.07.23285617; doi: https://doi.org/10.1101/2023.02.07.23285617
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (711)
- Anesthesia (204)
- Cardiovascular Medicine (2964)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12774)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4605)
- Geriatric Medicine (422)
- Health Economics (732)
- Health Informatics (2938)
- Health Policy (1070)
- Hematology (390)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4385)
- Nursing (237)
- Nutrition (642)
- Oncology (2282)
- Ophthalmology (649)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (499)
- Public and Global Health (6971)
- Radiology and Imaging (1538)
- Respiratory Medicine (917)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)